We are live on ! Find out more
RBC

Roble Belko & Company Portfolio holdings

AUM $925M
1-Year Est. Return 19.7%
This Fund
S&P 500
This Quarter Est. Return
-0.49%
1 Year Est. Return
+19.7%
3 Year Est. Return
+53.27%
5 Year Est. Return
+47.85%
10 Year Est. Return
+149.75%
AUM
$627M
AUM Growth
-$2.47M
Cap. Flow
+$2.94M
Cap. Flow %
0.47%
Top 10 Hldgs %
57.65%
Holding
461
New
41
Increased
97
Reduced
56
Closed
19
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VSS icon
101
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.9B
$213K 0.03%
1,842
-103
-5% -$12K
ADP icon
102
Automatic Data Processing
ADP
$108B
$210K 0.03%
688
-83
-11% -$25K
CRUS icon
103
Cirrus Logic
CRUS
$6.26B
$199K 0.03%
2,000
CTVA icon
104
Corteva
CTVA
$51.3B
$199K 0.03%
3,166
HEI.A icon
105
HEICO Corp Class A
HEI.A
$37.2B
$195K 0.03%
922
BA icon
106
Boeing
BA
$185B
$192K 0.03%
1,123
+601
+115% +$104K
IBDX icon
107
iShares iBonds Dec 2032 Term Corporate ETF
IBDX
$1.72B
$178K 0.03%
7,113
+976
+16% +$24.1K
DFIV icon
108
Dimensional International Value ETF
DFIV
$21.6B
$177K 0.03%
4,489
IJT icon
109
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.42B
$177K 0.03%
1,420
JEPI icon
110
JPMorgan Equity Premium Income ETF
JEPI
$45.9B
$173K 0.03%
3,027
+2,264
+297% +$132K
GOOGL icon
111
Alphabet (Google) Class A
GOOGL
$4.33T
$172K 0.03%
1,111
+41
+4% +$7.44K
VIG icon
112
Vanguard Dividend Appreciation ETF
VIG
$114B
$171K 0.03%
880
SCHD icon
113
Schwab US Dividend Equity ETF
SCHD
$105B
$170K 0.03%
6,086
+42
+0.7% +$1.17K
IWM icon
114
iShares Russell 2000 ETF
IWM
$83B
$164K 0.03%
820
+228
+39% +$49.5K
SHY icon
115
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
$163K 0.03%
1,966
+10
+0.5% +$822
DLN icon
116
WisdomTree US LargeCap Dividend Fund
DLN
$6.39B
$159K 0.03%
2,000
BSV icon
117
Vanguard Short-Term Bond ETF
BSV
$44.6B
$148K 0.02%
1,890
PFE icon
118
Pfizer
PFE
$153B
$143K 0.02%
5,661
-140
-2% -$3.66K
PEP icon
119
PepsiCo
PEP
$190B
$138K 0.02%
921
+300
+48% +$44.7K
CVS icon
120
CVS Health
CVS
$122B
$136K 0.02%
2,006
VRTX icon
121
Vertex Pharmaceuticals
VRTX
$126B
$135K 0.02%
279
META icon
122
Meta Platforms (Facebook)
META
$1.51T
$133K 0.02%
230
ENB icon
123
Enbridge
ENB
$112B
$132K 0.02%
2,973
MO icon
124
Altria Group
MO
$114B
$122K 0.02%
2,031
-454
-18% -$24.8K
SCHP icon
125
Schwab US TIPS ETF
SCHP
$16.3B
$117K 0.02%
4,334

Similar funds

Roble Belko & Company's Q1 2025 Portfolio in Review

As of Q1 2025, Roble Belko & Company held 461 positions worth $627M, down 0.39% from $629M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Roble Belko & Company's Q1 2025 filing shows 41 new, 97 increased, 56 reduced and 19 closed positions. Its largest new stake was Vanguard Russell 1000 ETF: 1,850 shares worth $470K. The largest sale was iShares Ultra Short Duration Bond Active ETF, an estimated $2.91M.

By sector, the portfolio is most concentrated in Technology at 1.6% of assets, down from 1.8% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Roble Belko & Company's largest Q1 2025 buy was Vanguard Russell 1000 ETF: 1,850 shares worth $470K.
  • Roble Belko & Company added most to State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF in Q1 2025, an estimated $4.85M increase.
  • Roble Belko & Company's biggest Q1 2025 reduction was iShares Ultra Short Duration Bond Active ETF, cutting an estimated $2.91M.
  • Roble Belko & Company fully exited iShares 7-10 Year Treasury Bond ETF in Q1 2025, selling an estimated $392K.
  • Roble Belko & Company's ten largest holdings make up 58% of its $627M portfolio in Q1 2025.
  • Roble Belko & Company opened 41 new positions and closed 19 in Q1 2025.
  • Roble Belko & Company's portfolio value fell 0.39% quarter-over-quarter to $627M.

Based on Roble Belko & Company's 13F filing for Q1 2025, filed 8 May 2025.